We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Documents relating to the new respiratory syncytial virus (RSV) vaccination programme.
Emakhandeni Clinic provides decentralised and integrated TB and HIV care in Bulawayo, Zimbabwe
The government is closely monitoring the spread of the Ebola virus in West Africa, and is taking action at home and abroad.
This cross-sectional study aimed to characterize the seroprevalence of alphaviruses and flaviviruses among children and adults
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).